HHealthcare Read More Novo Nordisk shares rise after Wegovy obesity pill launchJanuary 16, 2026 A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, US, on Thursday, Jan.…
AArtificial intelligence Read More Forget the bubble talk — why you need to own AI stocks in 2026January 4, 2026 I am tired of the lies, exaggerations, and dispersions that are constantly told in the assault on the…
MMedication Read More Novo Nordisk beyond weight loss has investors wary, scientists hopefulJanuary 1, 2026 Ozempic is medicine for adults with type 2 diabetes that along with diet and exercise may improve blood…
HHealthcare Read More Johnson & Johnson halts mid-stage trial of experimental eczema drugDecember 26, 2025 Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg |…
HHealthcare Read More Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on saleDecember 23, 2025 Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill…
HHealthcare Read More FDA approves first GLP-1 pill for obesity from Wegovy maker Novo NordiskDecember 22, 2025 The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the…
HHealthcare Read More Obesity pills from Novo Nordisk, Eli Lilly are comingDecember 16, 2025 Daniel Grill | Tetra Images | Getty Images A version of this article first appeared in CNBC’s Healthy…
HHealthcare Read More Eli Lilly to build $6 billion Alabama manufacturing plantDecember 10, 2025 Eli Lilly CEO David A. Ricks speaks at a press conference at Generation Park in Houston, Monday, Sept.…
HHealthcare Read More WHO backs use of GLP-1 therapies for obesity, warns access will remain limitedDecember 2, 2025 A view shows The World Health Organization (WHO) headquarters in Geneva, Switzerland, Jan. 28, 2025. Denis Balibouse |…
HHealthcare Read More Novo Nordisk stumbles against Eli Lilly in GLP-1 drug battle. Which stock is best?November 24, 2025 In the battle between weight-loss drug companies, Eli Lilly has emerged as the clear winner for investors. The…
HHealthcare Read More Eli Lilly hits $1 trillion market value, first for health care companyNovember 21, 2025 A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March…
HHealthcare Read More Novo Nordisk cuts cash prices for Wegovy, OzempicNovember 17, 2025 Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024.…